上海昊海生物科技股份有限公司（股票代码：06826）于2026年10月27日公告称，当日通过香港联交所场内回购H股6.25万股，占公司截至目前约2.2498亿股（不含库藏股）已发行股份总数的0.0278%。本次回购价格区间为每股15.78港元至16.10港元，合计支付约99.21万港元。
公司披露，截至10月27日，公司H股股本维持34,780,340股，A股股本为190,203,760股，另有3,848,095股A股处于库藏状态。根据此前于2026年5月29日通过的购回授权，公司获准回购不超过3,478,034股，目前已回购股份总数为1,023,800股，占授权通过时已发行股本的2.9436%。
公司同时确认，本次回购已获得董事会正式授权，并符合香港联合交易所证券上市规则及相关法律法规的要求。公告由公司董事兼联席公司秘书田敏签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.